Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 65.55% | -7.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 65.55% | -7.67% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 65.55% | -7.67% | |||
| SG&A Expenses | 9.39% | 31.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.00% | 20.97% | |||
| Operating Income | -38.53% | -21.64% | |||
| Income Before Tax | -46.56% | -28.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -46.56% | -28.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.56% | -28.38% | |||
| EBIT | -38.53% | -21.64% | |||
| EBITDA | -38.58% | -21.70% | |||
| EPS Basic | -46.15% | -6.67% | |||
| Normalized Basic EPS | -46.12% | -9.43% | |||
| EPS Diluted | -46.15% | -6.67% | |||
| Normalized Diluted EPS | -46.12% | -9.43% | |||
| Average Basic Shares Outstanding | 0.29% | 17.32% | |||
| Average Diluted Shares Outstanding | 0.29% | 17.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||